CheckMyRecalls

Teva Pharmaceuticals USA, Inc recalls Claravis (isotretinoin capsule

Published
29 Apr 2026
Units affected
5,101 cartons
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, with 3X10 blister pack NDC 0555-1054-60; Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.

Brand / company
Teva Pharmaceuticals USA, Inc
Codes / lots
Lots#: 100067507, 100067508, Exp 07/31/2026
Distribution
Nationwide in the USA, Puerto Rico and Virgin Islands
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 29 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.